Cl. Scott et al., Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice, EXP HEMATOL, 28(9), 2000, pp. 1001-1007
Objective. To examine the role of granulocyte-macrophage colony-stimulating
factor (GMC-SF) in thrombopoiesis.
Materials and Methods. Thrombopoietin-unresponsive mice (mpl null mice), wh
ich have a profound reduction in platelets and mature megakaryocytes, were
interbred with mice that do not respond to GM-CSF or interleukin 5 (beta c
null mice), and hematopoiesis was examined,
Results. In initial experiments on a mixed genetic background, double mutan
t mice (beta c/mpl null mice) showed an unexpected amelioration of the thro
mbocytopenia seen in mpl null mice. Platelet counts were elevated approxima
tely twofold in beta c/mpl null mice compared with mpl null mice (mpl null
73 +/- 31; beta c/mpl null 164 +/- 70; n = 10 to 29 mice per genotype, p <
0.00001). This was associated with lessening of the deficit of megakaryocyt
es, progenitor cells, and colony-forming units spleen seen in mpl null mice
, This amelioration of the mpl null phenotype in beta c/mpl null mice on a
mixed genetic background was highly statistically significant. To determine
whether this amelioration of phenotype was solely the consequence of loss
of pc signaling, progeny of a second intercross on a C57BL/6 background (B6
beta c/mpl null mice) were examined. When the resulting B6 beta c/mpl null
mice were analyzed and compared with B6mpl null littermates, the increase
in platelet count, hematopoietic progenitor cell number, and colony-forming
units spleen number was no longer observed.
Conclusions, There was no additional effect seen as a result of loss of bet
a c signaling. GM-CSF did not play a significant role in thrombopoiesis, ev
en in combination with the absence of thrombopoietin signaling. These resul
ts highlight problems that can be encountered when studying introduced muta
tions in mice. They exemplify the importance of eliminating the influence o
f modifying genes when attributing biologic differences to specific introdu
ced genetic alterations, (C) 2000 International Society for Experimental He
matology. Published by Elsevier Science Inc.